potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine

C62H58BBrKN19O7 — CID 162075804

IUPACpotassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine
SMILESCC(C)(C)OC(=O)n1cc(B2OC(C)(C)C(C)(C)O2)cn1.Cc1cccc(-c2nc3ncccn3c2-c2ccc3ncc(-c4cn[nH]c4)cc3n2)n1.Cc1cccc(-c2nc3ncccn3c2-c2ccc3ncc(Br)cc3n2)n1.Nc1ncccn1.O=CO[O-].[K+]
InChIInChI=1S/C23H16N8.C20H13BrN6.C14H23BN2O4.C4H5N3.CH2O3.K/c1-14-4-2-5-18(28-14)21-22(31-9-3-8-24-23(31)30-21)19-7-6-17-20(29-19)10-15(11-25-17)16-12-26-27-13-16;1-12-4-2-5-15(24-12)18-19(27-9-3-8-22-20(27)26-18)16-7-6-14-17(25-16)10-13(21)11-23-14;1-12(2,3)19-11(18)17-9-10(8-16-17)15-20-13(4,5)14(6,7)21-15;5-4-6-2-1-3-7-4;2-1-4-3;/h2-13H,1H3,(H,26,27);2-11H,1H3;8-9H,1-7H3;1-3H,(H2,5,6,7);1,3H;/q;;;;;+1/p-1
InChIKeyZBROGYHPIVCXIW-UHFFFAOYSA-M
MW1311.09 g/mol
LogP6.04
Rot. Bonds7

About potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine

potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine (PubChem CID 162075804) has the molecular formula C62H58BBrKN19O7 and a molecular weight of 1311.09 g/mol. Its IUPAC name is potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine.

Molecular Properties

Compound Namepotassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine
PubChem CID162075804
Molecular FormulaC62H58BBrKN19O7
Molecular Weight1311.09 g/mol
Exact Mass1309.37
IUPAC Namepotassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine
SMILESCC(C)(C)OC(=O)n1cc(B2OC(C)(C)C(C)(C)O2)cn1.Cc1cccc(-c2nc3ncccn3c2-c2ccc3ncc(-c4cn[nH]c4)cc3n2)n1.Cc1cccc(-c2nc3ncccn3c2-c2ccc3ncc(Br)cc3n2)n1.Nc1ncccn1.O=CO[O-].[K+]
InChIInChI=1S/C23H16N8.C20H13BrN6.C14H23BN2O4.C4H5N3.CH2O3.K/c1-14-4-2-5-18(28-14)21-22(31-9-3-8-24-23(31)30-21)19-7-6-17-20(29-19)10-15(11-25-17)16-12-26-27-13-16;1-12-4-2-5-15(24-12)18-19(27-9-3-8-22-20(27)26-18)16-7-6-14-17(25-16)10-13(21)11-23-14;1-12(2,3)19-11(18)17-9-10(8-16-17)15-20-13(4,5)14(6,7)21-15;5-4-6-2-1-3-7-4;2-1-4-3;/h2-13H,1H3,(H,26,27);2-11H,1H3;8-9H,1-7H3;1-3H,(H2,5,6,7);1,3H;/q;;;;;+1/p-1
InChIKeyZBROGYHPIVCXIW-UHFFFAOYSA-M
XLogP6.04
TPSA330.14 Ų
H-Bond Donors2
H-Bond Acceptors25
Rotatable Bonds7
Heavy Atoms91
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001311.09
LogP ≤ 56.04
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(4-bromo-1-ethylpyrazol-3-yl)-6-methylpyridine;2-(4-bromo-1H-pyrazol-5-yl)-6-methylpyridine;N-[6-[1-ethyl-3-(6-methyl-2-pyridinyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]formamide;6-[1-ethyl-3-(6-methyl-2-pyridinyl)pyrazol-4-yl]-3-isocyanoimidazo[1,2-a]pyridine;ethyl trifluoromethanesulfonate;3-isocyano-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine;methane
CID 157058004
tert-butyl N-[(4-amino-7-bromo-1-ethylimidazo[4,5-c]quinolin-2-yl)methyl]-N-ethylcarbamate;tert-butyl N-[[4-amino-1-ethyl-7-(2H-pyrrol-3-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylcarbamate;1-ethyl-2-(ethylaminomethyl)-7-(2H-pyrrol-3-yl)imidazo[4,5-c]quinolin-4-amine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CID 157615989
2-(bromomethyl)pyrazine;propan-2-yl (3S)-4-acetyl-7-bromo-3-methyl-2,3-dihydroquinoxaline-1-carboxylate;propan-2-yl (2S)-1-acetyl-2-methyl-6-[1-(pyrazin-2-ylmethyl)pyrazol-4-yl]-2,3-dihydropyrido[2,3-b]pyrazine-4-carboxylate;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]methyl]pyrazine
CID 158805818
1-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3,4-dihydro-2H-1,7-naphthyridin-1-yl]ethanone;1-[5-[3-(1H-benzimidazol-2-yl)-1-methylindazol-5-yl]-3,4-dihydro-2H-1,7-naphthyridin-1-yl]ethanone;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(1-(5-bromo-3,4-dihydro-2H-1,7-naphthyridin-1-yl)ethanone);5-bromo-1-methyl-3,4-dihydro-2H-1,7-naphthyridine;5-bromo-1,2,3,4-tetrahydro-1,7-naphthyridine
CID 158833290
2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone
CID 158977904
7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine;tert-butyl 4-(4-amino-5-bromopyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidine-1-carboxylate;tert-butyl 4-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,6-dihydro-2H-pyridine-1-carboxylate;tert-butyl 4-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidine-1-carboxylate;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylate
CID 159033814
6-bromo-3-fluoro-2-methylpyridine;6-(4-bromo-1-methylpyrazol-3-yl)-3-fluoro-2-methylpyridine;ethane;3-fluoro-2-methyl-6-(1-methylpyrazol-3-yl)pyridine;3-fluoro-2-methyl-6-(1H-pyrazol-5-yl)pyridine;6-[3-(5-fluoro-6-methyl-2-pyridinyl)-1-methylpyrazol-4-yl]-3-isocyanoimidazo[1,2-a]pyridine;iodomethane;3-isocyano-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CID 159106463
tert-butyl 3-bromo-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;[6-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyridin-3-yl]-1,5-naphthyridin-3-yl]boronic acid;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyridin-3-yl]-7-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)-1,5-naphthyridine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
CID 159535838
(9S)-N-(4-bromo-2-pyridinyl)-5-(2-methyl-4-pyridinyl)-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;(9S)-5-(2-methyl-4-pyridinyl)-N-[4-(1H-pyrazol-4-yl)-2-pyridinyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-8-carboxamide;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CID 159536131
2-(4-bromo-1-methylpyrazol-3-yl)-6-methylpyridine;2-(4-bromo-1H-pyrazol-5-yl)-6-methylpyridine;3-isocyano-6-[1-methyl-3-(6-methyl-2-pyridinyl)pyrazol-4-yl]imidazo[1,2-a]pyridine;3-isocyano-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine;methane;N-[6-[1-methyl-3-(6-methyl-2-pyridinyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]formamide
CID 159762963
CID 159895659
CID 159895659
1-benzyl-6-bromo-3H-imidazo[4,5-b]pyridin-2-one;3-N-benzyl-5-bromopyridine-2,3-diamine;1-benzyl-6-(2-methylpyrazol-3-yl)-3H-imidazo[4,5-b]pyridin-2-one;di(imidazol-1-yl)methanone;1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
CID 159958337

Frequently Asked Questions

What is the IUPAC name of potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine?
The IUPAC name of potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine (CID 162075804) is potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine.
What is the SMILES notation for potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine?
The canonical SMILES for potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine is CC(C)(C)OC(=O)n1cc(B2OC(C)(C)C(C)(C)O2)cn1.Cc1cccc(-c2nc3ncccn3c2-c2ccc3ncc(-c4cn[nH]c4)cc3n2)n1.Cc1cccc(-c2nc3ncccn3c2-c2ccc3ncc(Br)cc3n2)n1.Nc1ncccn1.O=CO[O-].[K+].
What is the InChIKey of potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine?
The InChIKey is ZBROGYHPIVCXIW-UHFFFAOYSA-M. The full InChI is InChI=1S/C23H16N8.C20H13BrN6.C14H23BN2O4.C4H5N3.CH2O3.K/c1-14-4-2-5-18(28-14)21-22(31-9-3-8-24-23(31)30-21)19-7-6-17-20(29-19)10-15(11-25-17)16-12-26-27-13-16;1-12-4-2-5-15(24-12)18-19(27-9-3-8-22-20(27)26-18)16-7-6-14-17(25-16)10-13(21)11-23-14;1-12(2,3)19-11(18)17-9-10(8-16-17)15-20-13(4,5)14(6,7)21-15;5-4-6-2-1-3-7-4;2-1-4-3;/h2-13H,1H3,(H,26,27);2-11H,1H3;8-9H,1-7H3;1-3H,(H2,5,6,7);1,3H;/q;;;;;+1/p-1.
What are the key properties of potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine?
potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine has a molecular weight of 1311.09 g/mol, XLogP of 6.04, 7 rotatable bonds, 2 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;7-bromo-2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-1,5-naphthyridine;tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate;2-[2-(6-methyl-2-pyridinyl)imidazo[1,2-a]pyrimidin-3-yl]-7-(1H-pyrazol-4-yl)-1,5-naphthyridine;oxido formate;pyrimidin-2-amine is sourced from PubChem (CID 162075804), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).